Torrent Pharma Gains on Citi Upgrade

  Published 1 year ago

Torrent Pharmaceuticals' stock price is rising after Citigroup increased its price target to ₹4,000 per share. This upgrade follows the company's recently announced Q4FY25 financial results, signaling positive analyst sentiment.

  • Citi raised Torrent Pharma's price target.
  • Upgrade driven by Q4FY25 results.
  • Stock is currently trading higher.

You might like these

Bandhan Bank Q1 Profit Falls 14%

Paraguay & India Partner on $150M Biofuel Plant

Rail Vikas Nigam Upgrades OHE for South Central Railway

India Bond Market Awaits Rate Decision

Aditya Birla Capital Q1 PBT Up 13%

Solara Pharma Turns Profitable in Q1

Deepak Fertilisers Signs LNG Deal

News that matters the most ⚡